HIV and Drug Abuse Interventions among Pregnant Women in Drug Abuse Treatment

The summary for the HIV and Drug Abuse Interventions among Pregnant Women in Drug Abuse Treatment grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

HIV and Drug Abuse Interventions among Pregnant Women in Drug Abuse Treatment: This RFA invites applications for studies testing interventions to prevent or reduce HIV risk among pregnant women in drug abuse treatment through: 1) targeted behavioral HIV prevention and risk reduction interventions; and 2) behavioral interventions aimed at improving adherence to prenatal care regimens among HIV-positive, pregnant drug-abusers. A total of $1.5 million is anticipated for funding approximately 4-6 meritorious research projects. The grant mechanisms eligible for funding through this RFA are the small grant (R03), the exploratory/developmental grant (R21), and the standard research grant (R01) mechanisms. Eligible institutions include for-profit, non-profit, domestic, foreign, public, private, and certain units of state and local government also faith and community based, eligible Federal. Eligible principal investigators are any applicants with the skills, knowledge, and resources to carry out the proposed research. An applicant may no! t submit more than one application in response to this RFA for which he or she is the Principal Investigator or Co-Investigator. An applicant who is the Principal Investigator on one application may serve as a consultant on other applications submitted in response to this RFA. Application materials are available through the NIH website (http://grants.nih.gov/grants/forms.htm), and technical assistance in preparing applications is available from the contact people listed in this announcement. Telecommunications for the hearing impaired is available at: TTY 301-451-0088.